SEC Form 3 · accession 0001193125-26-387926
Kura Oncology, Inc. · KURA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Fulk
Officer — Chief Financial Officer
Period of report
Sep 8, 2026
Accepted (ET)
Sep 10, 2026 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422143
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
No Table II lines on this filing.